Get started

Moderna

What May Happen to Moderna and Pfizer?International pharmaceutical giant Merck & Co announced the successful end of its clinical trial of the world’s first oral COVID-19 antiviral drug molnupiravir in the simple form of a pill. The company has claimed that molnupiravir effectively decreases the risk of hospitalization and death of sick individuals who have just contracted the virus or have advanced symptoms by half.  Moreover, the company also suggested that molnupiravir could be used to prevent the contraction of  the coronavirus. But what is most important at this stage is that fact that the clinical trials of molnupiravir showed high effectiveness against different COVID-19 variants, including the terrifying Delta variant. This seems to be good news for antivaxers or for anybody who is looking for an alternative prevention method from COVID-19 other than the vaccine.  Whether you agree or disagree with having the vaccine, it is worthwhile to consider this information as a means of expanding your investment portfolio with Merck stocks. Additionally, COVID-19 major vaccine producers Pfizer and Moderna stocks may suffer if the new pill is officially registered. Let’s take a look at Pfizer and Moderna’s price charts. Both stocks suffered a 50% correction from their peaks in August. Although, Pfizer business model is more diversified than that of Moderna’s, the technical picture shows that the upward trend for Pfizer stocks is more in danger. The reason for such fears is that over the last three consecutive trading sessions its stocks closed below the trend support line that started in February 2021. So, if Pfizer stock prices fail to recover above the $43.20-44 correction, they are likely to continue towards the $38.20-39.20 area. In this area, two important technical lines cross – one is the support line of the upward trend that started in March 2020 and the second – former resistance line that connects September 2020 and May, June 2021 highs. Pfizer and BioNTEch may have a trump of positive opinion by the Committee for Medicinal Products for Human Use (CHMP) for the administration of the Pfizer-BioNTech COVID-19 vaccine as a booster shot six months after the second dose, but this factor is already priced in. The Moderna stock prices chart seems to be more complex as it shows that the March 2020 long-term upward trend is supported by the upward trend that started in May 2021 in the area of $319-321. Even the correction from the peak of $496.71 closely echoes the ABC correction structure, where A and C waves are equal. And if so, Moderna stocks may recover both not only to recent highs, but to new all-time highs. Such a scenario might be activated if prices hold above the downward channel from August 10. In this case new targets may open at $563-565. Technical perspectives of Merck stocks will be reviewed in the coming comments.
NASDAQ:MRNALong
by scavoanastasiia
4
MODERNA POSSIBLE DISTRIBUTION!Hello my beauties. I think MRNA has entered a distribution range, as the ST (second test) seemed to be pretty weak, and the price is now showing weakness below the trading range. We are going to wait for further developments in price action and eventually take a trade on the final LPSY. For those of you who like trading ranges, this might be a juicy opportunity. Watch for the creation of an UT (upthrust) and an UTAD (upthrust after distribution) before you take your trade. If you find this idea to be helpful like, follow, and drop a comment below if you'd want me to analyse a different pair. Consider supporting me if you think I am providing you with value. Peace. Luca, TrickleDownFX
NASDAQ:MRNAShort
by TrickleDownFX
3
MRNA Daily TimeframeSNIPER STRATEGY (new version) It works ALMOST ON ANY CHART. It produces Weak, Medium and Strong signals based on consisting elements. NOT ALL TARGETS CAN BE ACHIEVED, let's make that clear. TARGETS OR ENTRY PRICES ARE STRONG SUPPORT AND RESISTANCE LEVELS. ENTRY PRICE BLACK COLOR TARGETS GREEN COLOR STOP LOSS RED COLOR DO NOT USE THIS STROTEGY FOR LEVERAGED TRADING. It will not give you the whole wave like any other strategy out there but it will give you a huge part of the wave. The BEST TIMEFRAMES for this strategy are Daily, Weekly and Monthly however it can work on any timeframe. Consider those points and you will have a huge advantage in the market. There is a lot more about this strategy. It can predict possible target and also give you almost exact buy or sell time on the spot. I am developing it even more so stay tuned and start to follow me for more signals and forecasts. START BELIEVING AND GOOD LUCK HADIMOZAYAN
NASDAQ:MRNAShort
by hadimozayan
MODERNA Daily TimeframeSNIPER STRATEGY This magical strategy works like a clock on almost any charts Although I have to say it can’t predict pullbacks, so I do not suggest this strategy for leverage trading. It will not give you the whole wave like any other strategy out there but it will give you huge part of the wave. The best timeframe for this strategy is Daily, Weekly and Monthly however it can work any timeframe above three minutes. Start believing in this strategy because it will reward believers with huge profit. There is a lot more about this strategy. It can predict and also it can give you almost exact buy or sell time on the spot. I am developing it even more so stay tuned and start to follow me for more signals and forecasts.
NASDAQ:MRNAShort
by hadimozayan
4
Moderna getting ready for a move higher, Maybe $500+ level(s)Ive been watching the recent uptick figuring there would be a place to sneak in and ride it down to ride back up even higher than it just moved since I missed that ride. She fell rite to my line and held rite around it. Personally i think the $386 level is in play but only if it continues down under $410. once it taps that line or the bottom of the triangle once maybe twice I believe it will make a new ATH over $500. I added some extras levels for reference.
NASDAQ:MRNAShort
by ahancovsky
$MRNA: a fine cup of coffee!After Pfiser's booster shot approval this month, $MRNA will surely follow. Today, they announced a combined flu and COVID shot, as well as signing a multi-year deal with a manufacturer, National Risilience Inc, which will help reach its 2021 goal of delivering 800M-1B doses of its vaccine. This has got the stock soaring and the rim of the cup is forming as you can see in my beautiful drawings. At least that's what my mom calls them. So, get ready for a pullback and then a trip to the moon! 😉🚀🚀🚀
NASDAQ:MRNALong
by alxiv
5
Moderna is choosing the ascending channelIt is not a prediction. This stock has chosen its channel (BULLISH). What's your opinion about $MRNA? What's your PT? Your comments are welcome. ############## Take into account that fundamentals (news) supplement technical analysis . A trader does not use a crystal ball to predict the future (news and people's reactions). Additionally technical analysis is not an exact science. It involves a degree of subjectivity. Legal disclaimer: I am not a financial advisor. The advice here given is not a financial advice even though my excitement might make it look like such. This account shouldn't be followed by anyone expecting something from me. You trade at your own risk and nobody can guarantee you results. Even if someone could, I don't.
NASDAQ:MRNALong
by ymarkets
Moderna: Can be a good time to buyThe Company will increase the number of participants in the study on the effectiveness of the vaccine on children between 6 months to 12 years old. In previous reports from the end of July, the company announced that 7,000 participants would participate in the study and now it is reported that following the FDA requirement, the company will increase the number of participants in the trial to 13,275. The company’s stock is down 15% in New York. Stock Price Target (Wall Street Journal) High $463.00 Median $271.50 Low $85.00 Average $290.83
NASDAQ:MRNALong
by JohnGoldman1
MRNA tells you the real story of the last year!Look at that parabolic move on the Weekly chart of Moderna. This one chart tells you whats really been going on this last 18 months. Remember when earlier this year we had EU & US politicians trying to undermine the AZN UK/Swe vaccine? Why? Because it was sold at cost as opposed to Moderna and Pfizers vaccines which sold for profit. Those politicians need those campaign dollars for re-election! Last week we had both Moderna and Pfizer raise the prices of the Covid 19 Vaccine Shots. The next day or so we heard Western Governments talking about how we'd all need to be taking 6 monthly booster shots of the vaccine. Any coincidence there perchance? Well you can see what impact all that has had on the MRNA share price. A 5-8 fold increase in the last 12-18 months. Nice work if you bought in early.
NASDAQ:MRNA
by FXTraderPaul
1
MRNA short after S&P 500 inclusionMRNA seems to follow a typical hypecycle pattern on the 15m Chart. I observed this pattern in ATOS in the last weeks on the 30min Chart and it ended with ATOS dropping like a rock. Keep in mind that just bcs ATOS dropped doesn't mean anything for MRNA. I expect the same to happen to MRNA since it is just fundamentally completely overvalued and I doubt the hype will sustain much longer. But the market in 2021 is a crazy hype-driven meme market, so who knows what happens. Just an idea and no financial advisory obviously. The risk I see is that the hype gets further fueled by news about more Covid outbreaks from the delta variant or from positive company internal news. Just fundamentally seen I would make a share offering if I were involved in the management team of MRNA to take advantage of the very high share price compared to fundamental value, but I am not involved in the company, so who knows what happens. I want to encourage the MRNA bulls to openly discuss their views here or in private messages. I am happy when you show me my current bear thesis is wrong and why. Disclosure: I am short MRNA. So my views are biased. Pls do your own due diligence and hit your own decisions.
NASDAQ:MRNAShort
by larsdanordic
5
Are Covid Stocks Coming Back?If there is any hope for the S&P right now it may very well come from the healthcare sector with mega blue chip Johnson & Johnson. JNJ has managed to put in consecutive higher highs and higher lows on the weekly, and now also is confirming support on the .618 fibonacci level at $165.40. However, there appears to still be much selling pressure at just above $168, so don't be surprised if we continue to see consolidation for another a week or two before getting the confirmed breakout above our red resistance line at the aforementioned $168 price level. If resistance at this level is broken, we will be seeing a possible retest of blue sky all time highs for the healthcare giant JNJ. In the meantime, I am liking the idea of small longs along the .618 ($165.40) area as long as the upward sloping green trend is not violated.
NYSE:JNJLong
by TradeVibez
Sunday Prep 7/18 - $MRNA SHORTThis is my main focus heading into Monday. It’s getting to be A+ up here. You can see it did a very similar move back in late November of last year. But if this is a repeat of that, then we would need a gap up Monday morning and that would have to hold up and gap 1 last time on Tuesday. Definitely no guarantees that is what is setting up. But I am definitely praying for the gap up tomorrow on this. If we get that, then I will be stalking for lower highs to set in and present some levels to have defined risk against. Remember, if/when this plays out, the downside is NOT just a few points. We are looking for 10,15, even 20pts of downside. If we don’t get the gap up, I will still be interested, but it won’t really be A+ at that point. We NEED this to stay extreme in order to have that big edge.
NASDAQ:MRNAShort
by TrueTraderOfficial
7
Moderna NASDAQ: MRNAI only ever got a few entries onto this position early on and have taken profit along the way mainly due to freaking me out with the volatility when we started spiking to 200 dollars back at the end of 2020. I chose to play some of the bio tech and pharma plays during early covid as a defensive play but also some high risk as the controversy around the vaccines could have significantly back fire on me but I took the punt anyway. As I mentioned I havent taken any new entries since jan 2021 and just riding what i have left now, but its one of those stocks that just keeps running for me with regret of not going in heavier or not taking profit early with partial position lol but thats the game isnt it, hindsight's a bitch. Not doing any fancy TA on this, simply just following the channels up and looking for reaction on the outer limit of the pitchfork (set to 1.618) any major break down of the mean and I may look for a top up but I feel its gone far enough and actually looking to de-risk soon and reduce position further. Probably going to bite me in ass here
NASDAQ:MRNALong
by DeNomics
7